verapamil has been researched along with Leukemia, Promyelocytic, Acute in 8 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although apoptosis occurred when its multidrugs resistance had been reversed by verapamil, compared with sensitive HL-60 cells, the time at which apoptosis happened delayed and the drug dosage increased." | 1.29 | [Apoptosis resistance and its reversal in harringtonine resistant cell line]. ( Chi, XS; Fang, M; Pang, DB; Xue, SB; Zhang, HQ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, T | 1 |
| Yue, S | 1 |
| Haugland, RP | 1 |
| Fang, M | 1 |
| Zhang, HQ | 2 |
| Xue, SB | 2 |
| Pang, DB | 1 |
| Chi, XS | 1 |
| Su, GM | 1 |
| Davey, MW | 2 |
| Davey, RA | 2 |
| Kidman, AD | 1 |
| Maslak, P | 1 |
| Hegewisch-Becker, S | 1 |
| Godfrey, L | 1 |
| Andreeff, M | 1 |
| Kizaki, M | 1 |
| Ueno, H | 1 |
| Yamazoe, Y | 1 |
| Shimada, M | 1 |
| Takayama, N | 1 |
| Muto, A | 1 |
| Matsushita, H | 1 |
| Nakajima, H | 1 |
| Morikawa, M | 1 |
| Koeffler, HP | 1 |
| Ikeda, Y | 1 |
| Mote, PA | 1 |
| Oliver, L | 1 |
| Wang, L | 1 |
| Wang, RH | 1 |
| He, NG | 1 |
| Cass, CE | 1 |
| Janowska-Wieczorek, A | 1 |
| Lynch, MA | 1 |
| Sheinin, H | 1 |
| Hindenburg, AA | 1 |
| Beck, WT | 1 |
8 other studies available for verapamil and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Burkitt Lymphoma; Calcium Channel | 1995 |
[Apoptosis resistance and its reversal in harringtonine resistant cell line].
Topics: Apoptosis; Drug Resistance, Multiple; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Tumor | 1994 |
Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells.
Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine | 1994 |
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemoth | 1994 |
Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein.
Topics: Antigens, Differentiation; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamil | 1996 |
Paclitaxel sensitizes multidrug resistant cells to radiation.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Death; Dose-Response Relationship, Drug; Drug Re | 1996 |
[Enhancement of antitumor activity of harringtonine in human leukemia-60 cells in vitro by verapamil].
Topics: Antineoplastic Agents; Drug Synergism; Harringtonines; Humans; Leukemia, Promyelocytic, Acute; Tumor | 1992 |
Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
Topics: Cell Division; Cell Line; Drug Resistance; Humans; Kinetics; Leukemia, Lymphoid; Leukemia, Promyeloc | 1989 |